Syk kinase inhibitors for rheumatoid arthritis: trials and tribulations
- PMID: 21279987
- DOI: 10.1002/art.30109
Syk kinase inhibitors for rheumatoid arthritis: trials and tribulations
Comment on
-
An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents.Arthritis Rheum. 2011 Feb;63(2):337-45. doi: 10.1002/art.30114. Arthritis Rheum. 2011. PMID: 21279990 Clinical Trial.
Similar articles
-
Healing the Syk through kinase inhibitors.N Engl J Med. 2010 Sep 30;363(14):1362-4. doi: 10.1056/NEJMe1006527. Epub 2010 Sep 22. N Engl J Med. 2010. PMID: 20879886 No abstract available.
-
Spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis.N Engl J Med. 2011 Jan 6;364(1):83; author reply 84. doi: 10.1056/NEJMc1012187. N Engl J Med. 2011. PMID: 21208114 No abstract available.
-
The status of fostamatinib in the treatment of rheumatoid arthritis.Expert Rev Clin Immunol. 2012 Sep;8(7):609-15. doi: 10.1586/eci.12.63. Expert Rev Clin Immunol. 2012. PMID: 23078058
-
Promising new treatments for rheumatoid arthritis - the kinase inhibitors.Bull NYU Hosp Jt Dis. 2011;69(3):233-7. Bull NYU Hosp Jt Dis. 2011. PMID: 22035435 Review.
-
Role of spleen tyrosine kinase inhibitors in the management of rheumatoid arthritis.Drugs. 2011 Jun 18;71(9):1121-32. doi: 10.2165/11591480-000000000-00000. Drugs. 2011. PMID: 21711059 Review.
Cited by
-
Cell-signaling therapy in rheumatoid arthritis.Curr Rheumatol Rep. 2013 Oct;15(10):368. doi: 10.1007/s11926-013-0368-5. Curr Rheumatol Rep. 2013. PMID: 23955067 Review.
-
A new 3-arylbenzofuran derivative EIE-2 reestablishes Treg-dependent tolerance in rheumatoid arthritis by targeting on Syk induced mTOR and PKCθ imbalance.Front Immunol. 2025 May 21;16:1524491. doi: 10.3389/fimmu.2025.1524491. eCollection 2025. Front Immunol. 2025. PMID: 40469311 Free PMC article.
-
Pathogenic intracellular and autoimmune mechanisms in urticaria and angioedema.Clin Rev Allergy Immunol. 2013 Aug;45(1):47-62. doi: 10.1007/s12016-012-8326-y. Clin Rev Allergy Immunol. 2013. PMID: 22674016 Review.
-
Protein kinase inhibitors in the treatment of inflammatory and autoimmune diseases.Clin Exp Immunol. 2014 Apr;176(1):1-10. doi: 10.1111/cei.12248. Clin Exp Immunol. 2014. PMID: 24313320 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous